VRTX EPS Estimates
Vertex Pharmaceuticals Incorporated
$549.04
+$18.28(+3.44%)
71
Overall
60
Value
90
Tech
63
Quality
Market Cap
$134.53B
Volume
1.83M
52W Range
$403.16 - $563.80
Target Price
$573.07
VRTX EPS estimates: the consensus estimate for Vertex Pharmaceuticals Incorporated's current fiscal year is $18.17 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
VRTX EPS Estimates
- EPS estimate, current quarter
- $4.36
- EPS estimate, next quarter
- $4.08
- EPS estimate, current year
- $18.17
- EPS estimate, next year
- $20.00
- EPS growth, 3-year
- +6.03%
| Fiscal year | EPS |
|---|---|
| 2025 | $15.46 |
| 2024 | $-2.08 |
| 2023 | $14.05 |
| 2022 | $12.97 |
| 2021 | $9.09 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | VRTX | $549.04 | +3.4% | 1.83M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Vertex Pharmaceuticals Incorporated Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW